Drugs / Tirapibep
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07250542 | Jul 2024 → Dec 2025 overdue | prostate cancer | baotai Liang | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tirapibep | “PD-1 monoclonal antibody (Tirapibep, 3mg/kg, intravenous infusion)” NCT07250542 ↗ |
| Modality | Monoclonal antibody | “PD-1 monoclonal antibody (Tirapibep, 3mg/kg, intravenous infusion)” NCT07250542 ↗ |
| Route | Intravenous | “3mg/kg, intravenous infusion” NCT07250542 ↗ |